COMMITTED TO DISCOVERING BEST-IN-CLASS THERAPIES
TO CONQUER INFLAMMATORY and immunologic DISEASES

RAPT Therapeutics Reports Fourth Quarter And Year End Financial Results

March 14, 2023



« back to news page